Are Brooks Lab. latest results good or bad?

Brooks Laboratories has reported its financial results for the quarter ending March 2025, showcasing a notable performance in several areas compared to previous quarters. The company achieved net sales of Rs 23.32 crore, which is the highest quarterly sales recorded in the last five quarters, reflecting a growth of 21.2% compared to the average net sales of Rs 19.24 crore over the preceding four quarters. This indicates a positive trend in sales performance.
In terms of profitability, Brooks Laboratories reported a profit before tax (PBT) of Rs -1.90 crore, which is the least negative figure in the last five quarters. Similarly, the profit after tax (PAT) reached Rs -1.46 crore, also the highest in this timeframe, suggesting an upward movement in profitability metrics. The earnings per share (EPS) stood at Rs -0.56, indicating an improvement in earnings for shareholders.

The quarterly results also show a quarter-on-quarter growth in net sales of 13.65% compared to a slight decline of -1.30% in the previous quarter. However, the consolidated net profit exhibited a growth of 31.46% compared to the previous quarter, which had a higher growth rate of 46.21%. The operating profit margin, excluding other income, was reported at 6.65%, with a slight decline in growth compared to the previous quarter.

It is noteworthy that the company saw an adjustment in its evaluation over the past three months. Overall, while there are signs of improvement in sales and profitability, the financial results present a mixed picture of operational performance for Brooks Laboratories.